Advanced or Metastatic Solid Tumors Recruiting Phase 1 Trials for Surufatinib (DB15106)

IndicationStatusPhase
DBCOND0034454 (Advanced or Metastatic Solid Tumors)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs